1. Home
  2. The Cancer Genome Atlas
  Subject:

The Cancer Genome Atlas   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Gene Prostate cancer DNA methylation Carcinoma Protein Microarray Messenger RNA Glioma Glioblastoma multiforme Breast cancer The Cancer Genome Atlas DNA Polymerase chain reaction Acid Prostatectomy Radiation therapy Prostate Gleason grading system Prostate-specific antigen Epigenetics CpG site Histone Metastasis Lymph node Chemotherapy Western blot Apoptosis Transcriptome Metabolism Magnetic resonance imaging Estrogen receptor Neu!
RELATED SUBJECTS:
The publications listed also have these subjects
Gene  19 times
Prostate cancer  7 times
DNA methylation  7 times
Carcinoma  7 times
Protein  6 times
Microarray  6 times
Messenger RNA  6 times
Glioma  6 times
Glioblastoma multiforme  6 times
Breast cancer  6 times
Adenocarcinoma  6 times
RNA  5 times
Metastasis  5 times
Immunohistochemistry  5 times
DNA  5 times
Survival analysis  4 times
Genome  4 times
Estrogen receptor  4 times
World Health Organization  3 times
Regression analysis  3 times
Prostate  3 times
Human papillomavirus infection  3 times
Growth factor  3 times
Gene ontology  3 times
Epigenetics  3 times
Chromatin  3 times
Biomarker  3 times
Western blot  2 times
Squamous cell carcinoma  2 times
Small interfering RNA  2 times
Reporter gene  2 times
Radiation therapy  2 times
RNA-Seq  2 times
Prostate-specific antigen  2 times
Progression-free survival  2 times
Phosphoinositide 3-kinase  2 times
Oncology  2 times
Molecular biology  2 times
MicroRNA  2 times
Mechanistic target of rapamycin  2 times
Mass spectrometry  2 times
Lysine  2 times
Kaplan–Meier estimator  2 times
KRAS  2 times
Isocitric acid  2 times
Histone  2 times
Histology  2 times
Gleason grading system  2 times
Flow cytometry  2 times
Endocrine system  2 times
CpG site  2 times
Central nervous system  2 times
Bioinformatics  2 times
Beta-catenin  2 times
BRAF (gene)  2 times
Apoptosis  2 times
Antigen  2 times
Acetylation  2 times
White blood cell  1 time
Univariate  1 time
Unfolded protein response  1 time
Tyrosine kinase  1 time
Tumor suppressor gene  1 time
Trastuzumab  1 time
Transfection  1 time
Transcriptome  1 time
Transcription factor  1 time
Tissue microarray  1 time
The Samples  1 time
Telomerase reverse transcriptase  1 time
Targeted therapy  1 time
TNBC  1 time
TMZ  1 time
T cell  1 time
Synovial sarcoma  1 time
Subtyping  1 time
Structural functionalism  1 time
Stomach cancer  1 time
Standard deviation  1 time
Sirolimus  1 time
Senescence  1 time
Schwannoma  1 time
Sarcoma  1 time
Saccharomyces cerevisiae  1 time
STAT3  1 time
Regulation of gene expression  1 time
Receiver operating characteristic  1 time
Real-time polymerase chain reaction  1 time
Quantile  1 time
Pyrosequencing  1 time
Protein kinase B  1 time
Proportional hazards model  1 time
Precision medicine  1 time
Polyploid  1 time
Polymerase chain reaction  1 time
Polymerase  1 time
Pheochromocytoma  1 time
Phenotype  1 time
Pearson product-moment correlation coefficient  1 time
Papillary thyroid cancer  1 time
P53  1 time
P110α  1 time
Ovulation  1 time
Ovarian cancer  1 time
Oncogene  1 time
Notch signaling pathway  1 time
Non-small-cell lung carcinoma  1 time
Non-alcoholic fatty liver disease  1 time
Neuroblastoma  1 time
Neu!  1 time
Network theory  1 time
Necrosis  1 time
National Center for Biotechnology Information  1 time
NCI-60  1 time
Myc  1 time
Munhwa Broadcasting Corporation  1 time
Multivariate analysis  1 time
Multidimensional scaling  1 time
Mouse  1 time
Mitochondrial DNA  1 time
Microtubule  1 time
Melanoma  1 time
Mayo Clinic  1 time
Magnetic resonance imaging  1 time
Machine learning  1 time
MHC class I  1 time
MAPK/ERK pathway  1 time
Luciferase  1 time
Long non-coding RNA  1 time
Logistic regression  1 time
Leiomyosarcoma  1 time
Kinase  1 time
KEGG  1 time
Integrin  1 time
Insulin-like growth factor 1 receptor  1 time
Indel  1 time
Immunotherapy  1 time
Immunoprecipitation  1 time
Immunofluorescence  1 time
Illumina dye sequencing  1 time
IDH1  1 time
Histone deacetylase  1 time
Genetic association  1 time
Formaldehyde  1 time
Focal adhesion  1 time
Fibronectin  1 time
Fibroblast growth factor  1 time
Everolimus  1 time
Esophageal cancer  1 time
Epithelium  1 time
Epistasis  1 time
Epigenomics  1 time
Epigenome  1 time
Enzyme inhibitor  1 time
Endothelium  1 time
Endothelin  1 time
Endometrium  1 time
Endometrial cancer  1 time
Ellipsoid  1 time
Disease  1 time
Deconvolution  1 time
Data mining  1 time
DNA sequencing  1 time
DNA polymerase  1 time
DNA microarray  1 time
Cytoscape  1 time
Cytoplasm  1 time
Cytokeratin  1 time
Cyclin D1  1 time
Colorectal cancer  1 time
Cluster analysis  1 time
Clinical trial  1 time
Clear cell renal cell carcinoma  1 time
Chain reaction  1 time
ChIP-sequencing  1 time
Cell cycle  1 time
Cancer immunotherapy  1 time
Cadherin  1 time
CD44  1 time
C-Raf  1 time
Building information modeling  1 time
Bisulfite sequencing  1 time
Biochemical cascade  1 time
Astrocytoma  1 time
Antigen presentation  1 time
Ant colony  1 time
Angiogenesis  1 time
Androgen receptor  1 time
Algorithm  1 time
Adrenal gland  1 time
Adjuvant  1 time
Adenoma  1 time
Acute myeloid leukemia  1 time
Acid  1 time
AKT1  1 time

Publications tagged with this subject: 43

Note: Top 50 publications shown only. Open an item panel to view more info


1. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis

2. Angiopoietin pathway gene expression associated with poor breast cancer survival

3. Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome

4. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status

5. Data normalization considerations for digital tumor dissection

6. Cancer metastasis: issues and challenges

7. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours

8. Key Genes in Stomach Adenocarcinoma Identified via Network Analysis of RNA-Seq Data

9. Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

10. Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins

11. Natural Agents-Mediated Targeting of Histone Deacetylases

12. Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer

13. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue

14. Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data

15. Bioinformatics analysis to screen the key prognostic genes in ovarian cancer

16. For robust big data analyses: a collection of 150 important pro-metastatic genes

17. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer

18. ING3 promotes prostate cancer growth by activating the androgen receptor

19. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT

20. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data

21. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes

22. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis

23. Assisted clustering of gene expression data using ANCut

24. Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas

25. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas

26. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery

27. Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers

28. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme

29. Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes

30. Gene expression markers of Tumor Infiltrating Leukocytes

31. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma

32. Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas

33. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes

34. Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach

35. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma

36. Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer

37. Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls

38. Migration of mitochondrial DNA in the nuclear genome of colorectal adenocarcinoma

39. MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis

40. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer

41. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA

42. Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates

43. High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer


Questions?

Drop us a message.